These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6107236)
21. Identification and urinary excretion of p-chlorophenoxyacetamide, a metabolite of iproclozide, in humans. De Sagher RM; De Leenheer AP; Cruyl AA; Claeys AE Drug Metab Dispos; 1975; 3(6):423-9. PubMed ID: 1217 [TBL] [Abstract][Full Text] [Related]
22. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index. Armstrong RD; Diasio RB Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343 [TBL] [Abstract][Full Text] [Related]
23. Biotransformation of the organic nitrate trans-N-(4-nitroxycyclohexyl)acetamide in dogs. Zell C; Neidlein R; Strein K Arzneimittelforschung; 1994 Sep; 44(9):1021-8. PubMed ID: 7986238 [TBL] [Abstract][Full Text] [Related]
24. The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites. de Jongh GD; van den Wildenberg HM; Nieuwenhuyse H; van der Veen F Drug Metab Dispos; 1981; 9(1):48-53. PubMed ID: 6111431 [TBL] [Abstract][Full Text] [Related]
25. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Glazer RI; Lloyd LS Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147 [TBL] [Abstract][Full Text] [Related]
26. Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil. Derissen EJ; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH J Pharm Biomed Anal; 2015 Jun; 110():58-66. PubMed ID: 25804433 [TBL] [Abstract][Full Text] [Related]
27. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia. Roobol C; De Dobbeleer GB; Bernheim JL Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011 [TBL] [Abstract][Full Text] [Related]
28. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats. Timchalk C; Smith FA; Bartels MJ Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263 [TBL] [Abstract][Full Text] [Related]
29. Quantification of 5-fluorouridine in human urine by capillary gas-liquid chromatography with a nitrogen-selective detector. De Leenheer AP; Gelijkens CF J Chromatogr Sci; 1978 Nov; 16(11):552-5. PubMed ID: 730817 [TBL] [Abstract][Full Text] [Related]
30. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850 [TBL] [Abstract][Full Text] [Related]
31. The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapol N-oxide metabolites. Usansky JI; Damani LA Drug Metab Dispos; 1992; 20(1):64-9. PubMed ID: 1346999 [TBL] [Abstract][Full Text] [Related]
32. 5-Fluorouracil derivatives. III. A simple method to prepare 5-fluoro-2'-deoxyuridine derivatives. Ozaki S; Watanabe Y; Hoshiko T; Ii S; Kagawa T Nucleic Acids Symp Ser; 1983; (12):9-12. PubMed ID: 6229716 [TBL] [Abstract][Full Text] [Related]
34. The metabolism of alpha-aminobenzo(b)thiophene-3-propionic acid (the sulfur analog of tryptophan) in the rat. Bosin TR; Bickers RG; Dinner A Drug Metab Dispos; 1978; 6(1):31-7. PubMed ID: 23271 [TBL] [Abstract][Full Text] [Related]
35. N-deethylation and N-oxidation of etamiphylline: identification of etamiphylline-N-oxide in greyhound urine by high performance liquid chromatography-mass spectrometry. Dumasia MC; Teale P J Pharm Biomed Anal; 2005 Jan; 36(5):1085-91. PubMed ID: 15620536 [TBL] [Abstract][Full Text] [Related]
36. Additive formation of antineoplastic 5-fluorouracil nucleosides from 5-fluorouracil by Ehrlich ascites tumor extracts in the presence of ribose 1-phosphate/uridine or deoxyribose 1-phosphate/deoxyuridine. Tamemasa O; Tezuka M J Pharmacobiodyn; 1982 Sep; 5(9):720-6. PubMed ID: 7153845 [TBL] [Abstract][Full Text] [Related]
37. Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metabolite. Jarman M; Foster AB; Goss PE; Griggs LJ; Howe I; Coombes RC Biomed Mass Spectrom; 1983 Nov; 10(11):620-5. PubMed ID: 6689274 [TBL] [Abstract][Full Text] [Related]
38. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system. Iigo M; Kuretani K; Hoshi A Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523 [TBL] [Abstract][Full Text] [Related]
39. Fluoropyrimidine treatment of ocular cicatricial disease. Heath TD; Lopez NG; Lewis GP; Stern WH Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):940-5. PubMed ID: 2940202 [TBL] [Abstract][Full Text] [Related]
40. [Isolation and identification of metabolites of 5-ethyl-2'-deoxyuridine from rat urine]. Kaul R; Hempel B Arzneimittelforschung; 1985; 35(7):1055-7. PubMed ID: 4052140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]